Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Leukemia, Myeloid, Acute 123Precursor Cell Lymphoblastic Leukemia-Lymphoma 105Myelodysplastic Syndromes 101Lymphoma, Non-Hodgkin 94Leukemia, Lymphocytic, Chronic, B-Cell 94Hodgkin Disease 88Multiple Myeloma 82Leukemia 73Lymphoma, Mantle-Cell 63Lymphoma, Follicular 62Lymphoma 62Lymphoma, Large B-Cell, Diffuse 59Myeloproliferative Disorders 55Lymphoma, B-Cell, Marginal Zone 55Leukemia, Myelogenous, Chronic, BCR-ABL Positive 54Burkitt Lymphoma 50Leukemia, Myelomonocytic, Chronic 48Congenital Abnormalities 46Leukemia, Myeloid, Chronic-Phase 45Lymphoma, Large-Cell, Immunoblastic 42Leukemia, Myeloid, Accelerated Phase 39Anemia, Refractory, with Excess of Blasts 36Hematologic Neoplasms 35Waldenstrom Macroglobulinemia 34Primary Myelofibrosis 34Graft vs Host Disease 34Blast Crisis 31Neoplasms, Plasma Cell 30Recurrence 28Dendritic Cell Sarcoma, Interdigitating 28

Interventions

Temozolomide 1Radiotherapy, Intensity-Modulated 1Mycophenolic Acid 1Magnetic Resonance Spectroscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Advanced Glioblastoma × Mycophenolic Acid × Clear all
NCT07605364 2026-05-26

Testing the Addition of an Anti-Cancer Drug, Mycophenolate Mofetil, to the Usual Treatment (Radiation Therapy and Temozolomide) for Advanced Brain Cancer

Alliance for Clinical Trials in Oncology

Phase 2/3 Not yet recruiting
422 enrolled
CNS

Advanced Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡